Algorae Pharmaceuticals Limited
LVCLF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$803 | -$2,096 | -$2,108 | -$1,957 |
| Dep. & Amort. | $0 | $0 | $1 | $1 |
| Deferred Tax | $0 | $0 | $1 | $45 |
| Stock-Based Comp. | $36 | $0 | -$1 | -$45 |
| Change in WC | $0 | -$35 | $99 | -$42 |
| Other Non-Cash | $766 | $607 | $21 | -$44 |
| Operating Cash Flow | -$1 | -$1,523 | -$1,986 | -$2,042 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$3,300 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $3,023 | $0 | $43 |
| Other Inv. Act. | $0 | $0 | $978 | $0 |
| Investing Cash Flow | $0 | -$277 | $978 | $39 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $2,290 |
| Stock Issued | $0 | $572 | $2,149 | $2,857 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$49 | -$299 | -$460 |
| Financing Cash Flow | -$0 | $523 | $1,850 | $4,686 |
| Forex Effect | $0 | -$2 | $8 | -$13 |
| Net Chg. in Cash | -$0 | -$1,280 | -$128 | $2,670 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $2,089 | $4,239 | $1,569 |
| End Cash | $0 | $808 | $4,111 | $4,239 |
| Free Cash Flow | -$1 | -$1,523 | -$1,986 | -$2,046 |